Table 1 The APC and CI for incidence of seven RIDs in the mainland of China during 2017–2021
RIDs | All reported cases | Clinically diagnosed cases | Laboratory-confirmed cases | ||||||
|---|---|---|---|---|---|---|---|---|---|
Joinpoint Year Range | APC (95% CI) | P | Joinpoint Year Range | APC (95% CI) | P | Joinpoint Year Range | APC (95% CI) | P | |
Seven RIDs | 2017–2021 | −1.42 (−39.14 to 57.09) | 0.96 | 2017–2021 | −6.15 (−45.43 to 53.48) | 0.84 | 2017–2021 | 12.15 (−18.67 to 59.49) | 0.56 |
Seasonal Influenza | 2017–2021 | −0.72 (−54.07 to 130.48) | 0.99 | 2017–2021 | −1.20 (−61.99 to 152.95) | 0.98 | 2017–2021 | 13.15 (−26.98 to 90.42) | 0.72 |
PTB | 2017–2021 | −7.53 (−12.31 to −2.79) | 0.009 | 2017–2021 | −18.37 (−26.83 to −10.76) | 0.002 | 2017–2021 | 8.10 (−0.46 to 17.94) | 0.06 |
Mumps | 2017–2021 | −17.02 (−36.50 to 3.32) | 0.19 | 2017–2021 | −17.30 (−37.36 to 3.71) | 0.19 | 2017–2021 | −0.42 (−17.65 to 19.85) | 0.96 |
Scarlet fever | 2017–2021 | −22.15 (−53.11 to 11.09) | 0.21 | 2017–2021 | −22.05 (−53.59 to 12.28) | 0.22 | 2017–2021 | −24.19 (−45.40 to −5.15) | 0.02 |
Pertussis | 2017–2021 | −10.31 (−66.13 to 90.68) | 0.72 | 2017–2021 | −11.68 (−63.15 to 77.21) | 0.70 | 2017–2021 | −7.13 (−60.92 to 83.31) | 0.78 |
Rubella | 2017–2021 | 29.35 (−74.18 to 540.89) | 0.81 | 2017–2021 | 7.71 (−75.11 to 362.20) | 0.94 | 2017–2021 | 37.09 (−76.49 to 787.58) | 0.77 |
Measles | 2017–2021 | −40.87 (−61.18 to −24.32) | 0.02 | 2017–2021 | −60.24 (−86.61 to −44.67) | 0.02 | 2017–2021 | −38.78 (−58.00 to −22.20) | 0.03 |